Preparation of budesonide–dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis

References

• Anderson BD, Taphouse V. (1981). Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate. J Pharm Sci, 70, 181–186.
   PubMed Web of Science ®Google Scholar
• Aslan AM, Temiz M, Atik E, Polat G, Sahinler N, Besirov E, Aban N, Parsak C. (2007). Effectiveness of mesalamine and propolis in experimental colitis. Adv Ther, 24, 1085–1097.
   PubMed Web of Science ®Google Scholar
• Bickston SJ, Cominelli F. (1998). Inflammatory bowel disease: short- and long-term treatments. Disease-a-Month, 44, 141–172.
   Google Scholar
• Binder V. (2004). Epidemiology of IBD during the twentieth century: an integrated view. Best Prac Res Clin Gastroenterol, 18, 463–479.
   PubMed Web of Science ®Google Scholar
• Braughler JM. (1985). Ester prodrugs of steroids. EP 156643.
   Google Scholar
• Canevari M, Castagliuolo I, Brun P, Cardin M, Schiavon M, Pasut G, Veronese FM. (2009). Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery. Int J Pharm, 368, 171–177.
   PubMed Web of Science ®Google Scholar
• Cooper HS, Murthy SNS, Shah RS, Sedergran D. (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest, 69, 238–249.
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SGM, Van Rees EP. (1998). Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immuno, 114, 385–391.
   PubMed Web of Science ®Google Scholar
• Edsbacker ST, Andersson T, McKeage K, Goa KL. (2004). Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn’s disease. Clin Pharmacokinet, 43, 803–821.
   PubMed Web of Science ®Google Scholar
• El-Medany A, Mahgoub A, Mustafa A, Arafa M, Morsi M. (2005). The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats. Eur J Pharmacol, 507, 291–299.
   PubMed Web of Science ®Google Scholar
• Fedorak RN, Bistritz L. (2005). Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv Drug Del Rev, 57, 303–316.
   PubMed Web of Science ®Google Scholar
• Friend DR. (1998). Issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease. Aliment Pharmacol Ther, 12, 591–603.
   PubMed Web of Science ®Google Scholar
• Gorgulu S, Yagci G. (2006). Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid induced colitis in rats. Dig Dis Sci, 51, 480–487.
   PubMed Web of Science ®Google Scholar
• Gupta M, Bhargava HN. (2006). Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide. J Pharm Biomed Anal, 40, 423–428.
   PubMed Web of Science ®Google Scholar
• Harboe E, Larsen C, Johansen M, Olesen HP. (1989). Macromolecular prodrugs. XV. Colon-targeted delivery—bioavailability of naproxen from orally administered dextran–naproxen ester prodrugs varying in molecular size in the pig. Pharm Res, 6, 919–923.
   PubMed Web of Science ®Google Scholar
• Klotz U, Schwab M. (2005). Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Del Rev, 57, 267–279.
   PubMed Web of Science ®Google Scholar
• Knigge KL. (2002). Inflammatory bowel disease. Clin Cornerstone, 4, 49–57.
   PubMedGoogle Scholar
• Lee JS, Jung YJ. (2001). Synthesis and properties of dextran–nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Dev Ind Pharm, 27, 331–336.
   PubMed Web of Science ®Google Scholar
• McKeage K, Goa KL. (2002). Budesonide (Entocort EC capsules): a review of its therapeutic use in the management of active Crohn’s disease in adults. Drugs, 62, 2263–2282.
   PubMed Web of Science ®Google Scholar
• McLeod AD, Friend DR. (1993). Synthesis and chemical stability of glucocorticoid–dextran esters: potential prodrugs for colon-specific delivery. Int J Pharm, 92, 105–114.
   Web of Science ®Google Scholar
• Mehvar R. (1999). Simultaneous analysis of dextran–methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography. J Pharm Biomed Anal, 19, 785–792.
   PubMed Web of Science ®Google Scholar
• Mehvar R. (2000). Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control Rel, 69, 1–25.
   PubMed Web of Science ®Google Scholar
• Paiva LAF, Gurgel LA. (2004). Protective effect of Copaifera langsdorffii oleo-resin against acetic acid-induced colitis in rats. J Ethnopharmacol, 93, 51–56.
   Google Scholar
• Pang YN, Zhang Y, Zhang ZR. (2002). Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting. World J Gastroenterol, 8, 913–917.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Antunez JA, Taboada C, Seijo B, Torres D. (2001). Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J Pharm Pharmacol, 53, 1207–1215.
   PubMed Web of Science ®Google Scholar
• Sellin J. (2005). Treatment targets in inflammatory bowel disease. Adv Drug Del Rev, 57, 217–218.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Tavakoli N, Fassihi A, Minaiyan M, Ahmadi F, Dorkoosh F. (2009). Synthesis and evaluation of dextran–budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis. Int J Pharm, 365, 69–76.
   PubMed Web of Science ®Google Scholar
• Williams DA, Lemke TL. (2002). Foye’s Principles of Medicinal Chemistry. Lippincott Williams & Wilkins, Philadelphia, US.
   Google Scholar
• Williams KL, Randall Fuller C, Dieleman LA, DaCosta CM, Haldeman KM, Balfour Sartor R, Kay Lund P. (2001). Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology, 120, 925–937.
   PubMed Web of Science ®Google Scholar
• Zou M, Okamoto H, Cheng G, Hao X, Sun J, Cui F., Danjo K. (2005). Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems. Eur J Pharm Biopharm, 59, 155–160.
   PubMed Web of Science ®Google Scholar